TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology-01 and -02 Studies - Marketscreener.com

1 min to read

News

February 17, 2023

TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology-01 and -02 Studies – Marketscreener.com

TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology-01 and -02 Studies Marketscreener.com
Source: TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology-01 and -02 Studies – Marketscreener.com

Tags: SPACs

Priveterra Acquisition Moves Today’s Merger Vote on Aeon Biopharma to June 9

Priveterra Acquisition in an 8-K filed this morning said today’s shareholder meeting to vote on the proposed merger with Aeon...
Alpha Star Acquisition Wants to Move Deal Dealine to March 2024

Alpha Star Acquisition in a proxy filing seeks a deadline extension until March 2024 while it continues to work on...
Corporate Briefing – June 2023

Welcome to the Corporate Briefing, where we review the latest developments in UK corporate law that you need to know...
Viveon Health Acquisition Eyes New March 2024 Deadline to Complete Clearday Deal

Viveon Health Acquisition in a proxy fining today seeks shareholder approval to extend its runway on a proposed merger with...
Inside the Courts – An Update From Skadden Securities Litigators – May 2023

Supreme Court Hears Argument on Traceability Requirement in Circuit-Split Slack v. Pirani - Key Points - - Before the end...

#SPACs

spacHero.com - SPAC Bot @spacherobot ·

3 Apr

Completed #SPACs market cap/daily change (pre-market):

$BRDS 2M
$GOEV 2M
$FFIE 2M
$SOUN 1M
$VORB 1M
$BBAI 575K
$IONQ 501K
$NKLA 324K
$LCID 259K
...$GRRR 252K

Interactive chart: http://www.spachero.com/heatmap/despac/
06:00:19 04/03/2023

Reply on Twitter 1642874672391004161 Retweet on Twitter 1642874672391004161 Like on Twitter 1642874672391004161 Twitter 1642874672391004161

spacHero.com - SPAC Bot @spacherobot ·

3 Apr

de-#SPACs ranked by pre-market volume:

$BRDS 2M
$GOEV 2M
$FFIE 2M
$SOUN 1M
$VORB 1M
$BBAI 575K
$IONQ 501K
$NKLA 324K
$LCID 259K
$GRRR 252K

...http://www.spachero.com/top50/despac #volume #SPAC
05:58:28 04/03/2023

Reply on Twitter 1642874205770481665 Retweet on Twitter 1642874205770481665 Like on Twitter 1642874205770481665 1 Twitter 1642874205770481665

spacHero.com - SPAC Bot @spacherobot ·

3 Apr

#SPACs ranked by volume (pre-market):

$DWAC 19K
$IQMD 310
$JWSM 123
$BSGA 103
$HPLT 100
$IPOF 0
$SLAC 0
$SGII 0
$SHAC 0
$SHQA 0

...http://www.spacHero.com #volume
05:50:15 04/03/2023

Reply on Twitter 1642872138184163329 Retweet on Twitter 1642872138184163329 Like on Twitter 1642872138184163329 Twitter 1642872138184163329

Renaissance Capital @ipotweet ·

3 Apr

The $IPO Market’s Winners and Losers Last Week – April 2, 2023 𝘳𝘦𝘢𝘥 𝘰𝘯... ...https://www.linkedin.com/pulse/ipo-markets-winners-losers-last-week-april-2-2023

#etfs #renaissancecapital #spacs #newstocks $IPOS

Reply on Twitter 1642835220926812160 Retweet on Twitter 1642835220926812160 Like on Twitter 1642835220926812160 Twitter 1642835220926812160